Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore Medical Dialogues Bureau1 Feb 2020 9:45 AM IST Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
SEBI exempts Trust from making open offers for Torrent Group Companies MD bureau15 Jan 2020 10:00 AM IST The trust currently does not hold any shares in these three firms. Pursuant to the scheme of amalgamation, the trust will hold over 71.2 per cent...
Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore Farhat Nasim25 Nov 2019 12:00 PM ISTThe investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the...
Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others Medical Dialogues Bureau29 Jan 2019 9:20 AM ISTIn a tweet Friday, the Competition Commission of India (CCI) said it "approves the acquisition of shares in Zydus Wellness Limited by True North...
Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd Ruby Khatun Khatun9 Sept 2018 10:15 AM ISTNew Delhi: Fortis Healthcare said that its step-down subsidiary RHT Health Trust Manager has sold 15 lakh shares in RHT Health Trust to Fortis...
Natco Pharma raises Rs 915 crore via QIP Ruby Khatun Khatun15 Dec 2017 10:36 AM ISTNew Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 9:30 AM ISTDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal Ruby Khatun Khatun22 Nov 2017 10:45 AM ISTNew Delhi: Shares of Eris Lifesciences and Strides Shasun rose by as much as 7 percent after both the companies entered into a definitive pact to buy...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 9:15 AM ISTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Dr Reddys receives EIR for Srikakulam plant, shares soar Ruby Khatun Khatun22 Sept 2017 10:29 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...
